Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of Grazax with Antihistamine in Grass Pollen Allergy
NCT01740284Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Sep 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of desloratadine in seasonal allergic rhinoconjunctivitis (SARC), sponsored by ALK-Abelló. Started Sep 2008; status: completed.
02
Drugs
desloratadine
03
Conditions
seasonal allergic rhinoconjunctivitis (SARC)
Beyond the preview
Go deeper on NCT01740284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01740284.